Literature DB >> 12676123

Susceptibility to fungal infections of nails in patients with primary antibody deficiency.

Anna B Macura1, Anna Macura-Biegun, Bolesław Pawlik.   

Abstract

Primary antibody deficiencies are rare diseases, which require early treatment with intravenous immunoglobulins to prevent fatal infections. The cell mediated immunity in patients with those immunodeficiencies remains unimpaired and usually they do not develop fungal infections. The aim of the study was to determine the susceptibility to fungal infections of nails in children with X-linked agammaglobulinaemia (XLA) and common variable immunodeficiency (CVID). Nail plate fragments collected from five patients with XLA and five with CVID were experimentally infected with a Candida albicans and Trichophyton mentagrophytes strains. The same procedures were carried out with the nails from a control group of 10 healthy volunteers. The intensity of the infection was evaluated on the basis of hyphae ingrown into the nail fragments. The main finding of the study was the increased susceptibility of antibody deficient patients to experimental nail infection with C. albicans and T. mentagrophytes.

Entities:  

Mesh:

Year:  2003        PMID: 12676123     DOI: 10.1016/S0147-9571(02)00051-6

Source DB:  PubMed          Journal:  Comp Immunol Microbiol Infect Dis        ISSN: 0147-9571            Impact factor:   2.268


  2 in total

Review 1.  Fungal infections in primary immunodeficiencies.

Authors:  Charalampos Antachopoulos; Thomas J Walsh; Emmanuel Roilides
Journal:  Eur J Pediatr       Date:  2007-06-06       Impact factor: 3.183

2.  Atypical Presentation of Severe Fungal Necrotizing Fasciitis in a Patient with X-Linked Agammaglobulinemia.

Authors:  Chai Teng Chear; Revathy Nallusamy; Kwai Cheng Chan; Ratna Mohd Tap; Mohd Farid Baharin; Sharifah Nurul Husna Syed Yahya; Prasobhan Bala Krishnan; Saharuddin Bin Mohamad; Adiratna Mat Ripen
Journal:  J Clin Immunol       Date:  2021-03-13       Impact factor: 8.317

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.